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Abstract 
Paratuberculosis (PTB) or Johne’s disease is a contagious enteritis of ruminants caused by Mycobacterium avium subsp. 
paratuberculosis (MAP). Ovine PTB is less understood than bovine PTB, especially concerning paucibacillary infection 
and its evolution into clinical disease. We combined shotgun proteomics, histopathology and immunohistochemistry 
for the characterization of ileal tissues collected from seven asymptomatic sheep negative to serum ELISA, positive to 
feces and tissue MAP IS900 and F57 PCR, histologically classified as paucibacillary, actively infected, together with 3 
MAP-free controls (K). Following shotgun proteomics with label-free quantitation and differential analysis, 96 proteins 
were significantly changed in PTB vs K, and were mostly involved in immune defense processes and in the mac-
rophage-MAP interaction. Principal component analysis (PCA) of protein abundances highlighted two PTB sample 
clusters, PTB1 and PTB2, indicating a dichotomy in their proteomic profiles. This was in line with the PCA of histopa-
thology data and was related to features of type 2 (PTB1) and type 3a (PTB2) lesions, respectively. PTB2 proteomes dif-
fered more than PTB1 proteomes from K: 43 proteins changed significantly only in PTB2 and 11 only in PTB1. The dif-
ferential proteins cathelicidin, haptoglobin, S100A8 and S100A9 were evaluated by immunohistochemistry. K tissues 
were negative to cathelicidin and haptoglobin and sparsely positive to S100A8 and S100A9. PTB tissues were positive 
to all four proteins, with significantly more cells in PTB2 than in PTB1. In conclusion, we described several pathways 
altered in paucibacillary PTB, highlighted some proteomic differences among paucibacillary PTB cases, and identified 
potential markers for disease understanding, staging, and detection.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Paratuberculosis (PTB) or Johne’s disease is a chronic, 
contagious enteritis of ruminants caused by Mycobac-
terium avium subspecies paratuberculosis (MAP). PTB 
is especially relevant in farmed ruminants [1–4] for the 
economic consequences caused by increase in mortal-
ity, decrease in milk production, and weight loss [5, 6]. In 
addition, viable MAP can be found in pasteurized milk 
and milk products with a potential risk of zoonotic trans-
mission [7–9].
MAP and its role in PTB have been the subject of 
numerous studies on disease progression and evolution 
in cattle. Our knowledge in this respect has increased 
considerably, but some aspects remain unclear also in 
this species, and more effective tools for disease diagno-
sis and control are still needed [10]. MAP transmission 
can occur by the fecal–oral route, in utero, and by inges-
tion of contaminated colostrum or milk [10–15]. Once 
the bacterium reaches the intestine, it is taken up by M 
cells and translocated across the intestinal mucosa, where 
it is internalized by naive macrophages and can lead to 
persistent infection [16]. In cattle, the disease typically 
goes from an early subclinical, paucibacillary phase to a 
later multibacillary phase with severe clinical manifes-
tations of the disease that include wasting and profuse, 
watery diarrhea [10]. In sheep, PTB is more insidious and 
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classification is less clearly defined [2, 17], leading to a 
great underestimation of its worldwide diffusion. Accord-
ing to several authors, the largest number of sheep in an 
affected flock are infected but asymptomatic [18, 19]. 
These can either have a latent infection, encompassing 
the presence of MAP in tissues without signs of disease 
(subclinical infection), or an active infection, in which 
histological signs of the disease can be observed (sub-
clinical disease) [20, 21]. A histological scoring system 
[22] classifies these signs into mild lesions represented 
by small focal granulomata of epithelioid cells limited to 
the Peyer patches (type 1) or extending to the adjacent 
mucosa (type 2), and more severe lesions with a multi-
focal cellular infiltration in mucosal areas not associated 
with lymphoid tissues and extending into the submucosa, 
with thickening of the mucosa and atrophy of villi (type 
3a). According to Pérez and coworkers [22], symptomatic 
animals with the end-point disease (clinical disease) pre-
sent two different types of lesion, lepromatous (type 3b) 
or tuberculoid (type 3c). Based on the degree of coloni-
zation, lesions can also be classified into paucibacillary, 
with few or no acid-fast bacilli (AFB), and multibacillary, 
with abundant AFB. Type 1, 2 and 3c lesions are pauci-
bacillary, while type 3b are multibacillary. Type 3a lesions 
are mainly paucibacillary, but multibacillary patterns 
can also be present, indicating that a crucial “transition 
stage” may occur in animals with this type of lesions [22]. 
Actively infected sheep with the subclinical disease can 
either remain such for their whole life, acting as MAP 
reservoirs and shedders, or develop clinical disease by 
showing either paucibacillary (3c) or multibacillary (3b) 
lesions. At present, factors, pathways, stages and dynam-
ics of disease progression are not completely understood 
[20], and the best diagnostic approach remains post-
mortem evaluation with histopathology image analysis, 
which represents the best indicator to confirm PTB and 
define its stage [1, 2, 23, 24].
The availability of detailed information on the prot-
eomic alterations introduced in ovine ileal tissues by the 
subclinical, paucibacillary, active MAP infection would 
provide novel information for understanding disease 
mechanisms, discover protein markers with potential for 
disease staging and, possibly, indicate host proteins that 
may be shed and detected in feces in vivo. This would also 
help experimental infection studies aimed at understand-
ing PTB progression to clinical disease. Currently, how-
ever, proteomic information on MAP-infected tissues is 
limited to a preliminary study recently published by our 
research group and describing the changes occurring in 
the ileum of sheep with multibacillary, clinical PTB [25].
In this study, we combined histopathology, proteom-
ics, and immunohistochemistry for the characterization 
of paucibacillary MAP lesions found in actively infected, 
subclinical sheep. Ileal tissues of asymptomatic, serum 
ELISA-negative, feces and tissue PCR-positive sheep 
were subjected to histopathological analysis and those 
classified as paucibacillary PTB were analyzed by shot-
gun proteomics in comparison to MAP-free controls. 
Differential proteins were investigated for host pathways 
activated during infection. Finally, proteins of inter-
est were evaluated by immunohistochemistry in MAP-
infected tissues and in MAP-free controls.
Materials and methods
Animals and tissues
Sheep ileal tissues used for the study belonged to a MAP-
positive flock of Sarda sheep (N = 174). The flock was 
monitored by the farm veterinarian under an owner vol-
untary basis by clinical examination, evaluation of PTB 
symptoms, serological screening by ELISA for presence 
of anti-MAP antibodies in serum (IDEXX Laboratories, 
Inc., Westbrook, MA, USA), and IS900 and F57 PCR 
for presence of MAP in feces, as described previously 
[25]. Out of 174 sheep, 21 were both ELISA and PCR-
positive, 20 were ELISA-positive and PCR-negative, and 
15 were ELISA-negative and PCR-positive. The latter 15 
were identified as those most probably affected by pauci-
bacillary paraTBC. At routine slaughtering, the intes-
tinal packages belonging to these 15 sheep (all females 
between 3 and 4  years of age) were retrieved at the 
slaughterhouse and brought to the Department of Veteri-
nary Medicine at the University of Sassari for gross path-
ological anatomy examination. Separate aliquots of tissue 
from the proximal, intermediate, and distal ileum (N = 45 
tissue samples) were collected from each sheep. Matched 
tissue aliquots were frozen at −80  °C or formalin-fixed 
and paraffin embedded for downstream molecular and 
histopathological characterization.
Histopathological analysis and molecular characterization 
of ileal lesions
Three micrometre sections from paraffin-embedded tis-
sue blocks from each ileal tract were subjected to hae-
matoxylin–eosin and Ziehl–Neelsen (ZN) staining and 
examined to confirm presence of MAP and associated 
lesions. PCR was carried out on all 45 frozen tissues sam-
ples for confirmation of MAP infection, as described pre-
viously [25]. Briefly, DNA was isolated with the  DNeasy® 
Blood and Tissue kit (Qiagen, Hilden, Germany), and 
tested for presence of the MAP specific sequences IS900 
and F57 by qualitative PCR. The MAP type was also char-
acterized by IS1311, RFLP, and sequencing, as described 
previously [25, 26]. All 15 tested animals carried the 
sheep MAP strain (S). FFPE tissue sections obtained 
from the proximal, intermediate, and distal ileum of the 
15 ELISA-negative, PCR-positive sheep (N = 45 tissue 
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samples) were evaluated by histopathological analysis. 
Out of these 15 sheep, 7 showed histopathological lesions 
compatible with paucibacillary paraTBC and were 
selected for proteomic analysis (Additional file 1). Nega-
tive control tissues (K) were obtained from three sheep 
of a certified MAP-free flock. K sheep were negative to 
serum ELISA and feces PCR. Their intestinal tissues were 
negative to PCR, microscopical evaluation and Ziehl–
Neelsen staining, and showed normal anatomy and 
histology.
Tissue processing for protein extraction and shotgun 
proteomic analysis
Tissue sample preparation was carried out as previously 
described [25]. Briefly, 100  mg of tissue from the distal 
ileum of the 7 PTB and 3 K sheep (N = 10 tissue samples) 
was minced with a sterile knife, placed in Eppendorf safe-
lock tubes (Eppendorf, Hamburg, Germany), immersed 
in extraction buffer and subjected to homogenization in 
a TissueLyser mechanical homogenizer (Qiagen, Hilden, 
Germany) followed by three cycles of sonication and 
freeze-thawing. Then, the extract was clarified by cen-
trifugation, subjected to nucleic acid digestion, and pro-
tein concentration was determined. Extracts and residual 
pellets (N = 20) were processed by filter-aided sample 
preparation (FASP). Briefly, protein samples were sub-
jected to reduction, alkylation, and trypsin digestion on 
Amicon Ultra-0.5 centrifugal filter units with Ultracel-10 
membrane (Millipore, Billerica, MA, USA) to obtain 
sample digests for shotgun proteomic analysis. Peptide 
concentration of digests was determined by measur-
ing absorbance at 280 nm with a NanoDrop 2000 spec-
trophotometer (Thermo Scientific, San Jose, CA, USA) 
using MassPREP E. coli Digest Standard (Waters, Mil-
ford, MA, USA) to create a calibration curve.
Shotgun proteomic analysis of peptides
All peptide mixtures were analyzed by liquid chroma-
tography-tandem mass spectrometry (LC–MS/MS) in 
duplicate runs (two technical replicates for each peptide 
mixture) on a Q-Exactive interfaced with an UltiMate 
3000 RSLCnanoLC system (Thermo Scientific, San Jose, 
CA, USA), as described previously [27]. Four micro-
gram of each peptide mixture were concentrated and 
washed onto a trapping precolumn (Acclaim PepMap 
C18, 75 µm × 2 cm nanoViper, 3 µm, 100 Å, Thermo Sci-
entific) and fractionated on a C18 RP column (Acclaim 
PepMap RSLC C18, 75  µm × 50  cm nanoViper, 2  µm, 
100  Å, Thermo Scientific) at a flow rate  of 250  nL/min 
using a linear gradient of 245 min from 5 to 37.5% elu-
ent B (0.1% formic acid in 80% acetonitrile) in eluent A 
(0.1% formic acid). Fragmentation occurred by higher 
energy collisional dissociation (HCD) and nitrogen as the 
collision gas. Proteome Discoverer (version 1.4; Thermo 
Scientific, Bremen, Germany) was used for protein iden-
tification using Sequest-HT as search engine. Each MS/
MS spectrum was analyzed as follows. Database: Bos 
taurus, Ovis aries, and Mycobacterium avium down-
loaded from UniProtKB/Swiss-Prot (release 2017 06); 
enzyme: trypsin, with two missed cleavages allowed; 
precursor mass tolerance: 10  ppm; MS/MS tolerance: 
0.02 Da; charge states: + 2, + 3, and + 4; cysteine carba-
midomethylation as static modification and methionine 
oxidation as dynamic modifications. The percolator algo-
rithm [28, 29] was used for assessing the significance of 
protein identification (P < 0.01) and for peptide validation 
(false discovery rate, FDR, < 0.01%) [28, 30]. Only rank 
1 peptides and only proteins identified with at least two 
peptides and two spectral counts were considered. Pep-
tide and protein grouping according to the Proteome 
Discoverer’s algorithm were allowed, applying the strict 
maximum parsimony principle. The protein list for each 
intestinal sample was built up by merging the data from 
the LC–MS/MS runs of the protein extract and of the 
residual pellet, generating 10 protein identification lists 
(1 for each sheep sample). For proteins having more than 
one entry, only those with the highest number of unique 
peptides and spectral counts (SpC) were selected for 
downstream analyses.
Principal component analysis and hierarchical clustering 
of samples
Principal component analysis (PCA) and hierarchi-
cal clustering of samples according to proteomic results 
were carried out based on the normalized spectral abun-
dance factor (NSAF) values of all identified proteins, 
obtained according to Old et  al. [31], as an indicator of 
protein abundance [32]. PCA and hierarchical clustering 
of samples according to histopathological results were 
carried out based on the scores generated upon detailed 
histological assessment by two observers grading from 
0 (absence of feature) to 3 (maximum degree of feature) 
and reported in Additional file 1. Data analysis was car-
ried out with Perseus (v.1.6.0.7).
Differential proteomic analysis
To estimate protein abundance and to compare the lev-
els of the same protein among sample groups, a spec-
tral counting approach was applied as described by Old 
et al. [31] and Zybailov et al. [33]. The  RSC, that is the  log2 
ratio of protein abundances between two experimental 
groups, was calculated as described previously [34] and 
expressed as fold change (FC) [25]. Statistical significance 
of differences in protein abundance was assessed by the 
beta-binomial test with FDR correction by Benjamini-
Hochberg [35, 36]. Only proteins with FC ≥ 2 or ≤ −2, 
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with a p-value ≤ 0.05 and present in at least two sam-
ples of each group being compared were considered 
significant.
STRING analysis
To investigate the biological role of differential proteins, 
their functional association at a system level [37] was 
assessed by performing a knowledge-based protein–pro-
tein interaction network analysis by means of the bio-
logical interface and web resource STRING (version 10.5) 
after replacing all Ovis aries UniProt IDs with the cor-
responding Bos taurus UniProt IDs. Specifically, KEGG 
enrichment analysis was aimed at mapping the differen-
tial proteins in biological pathways, while gene ontology 
(GO) analysis was aimed at mapping them into biological 
processes (BP), molecular functions (MF), and cellular 
components (CC).
Immunohistochemistry
Immunohistochemistry (IHC) was carried out as 
described previously [38]. Antibodies and dilutions were 
as follows: rabbit anti-CAMP (Sigma-Aldrich), 1:1500; 
rabbit anti-S100A8 (Sigma-Aldrich), 1:1000; rabbit anti-
haptoglobin (Thermo Fisher Scientific), 1:100; rabbit anti-
S100A9 (Sigma-Aldrich), 1:1000. Signal evaluation was 
carried out by counting positive cells in 10 random fields 
at 200× magnification (PC). Statistical analysis of IHC 
results was carried out with GraphPad Prism version 5.03 
for Windows (GraphPad Software, La Jolla, CA). Accord-
ing to the Shapiro–Wilk normality test the data followed 
a non-normal distribution, and a nonparametric Mann–
Whitney U-test was therefore applied.
Results
Shotgun proteomic results, principal component analysis, 
and hierarchical clustering
A total of 2350 and 2292 proteins were identified in PTB 
and in K samples, respectively. Details on proteins, pep-
tides, PSMs and search inputs are reported in Additional 
files 2 and 3. PCA and hierarchical clustering based on 
protein abundance values (NSAFs as reported in Addi-
tional file 3) generated three main clusters: one including 
all K samples, one including three PTB samples (P4, P6, 
and P7) and one including four PTB samples (P1, P2, P3, 
and P5) (Figures 1A and B). K and PTB1 were separated 
from PTB2 by the first component (16.4%), while K was 
separated from PTB1 by the second component (11.5%). 
PCA and hierarchical clustering based on a detailed his-
topathological analysis with grading scores (Additional 
file 1) produced similar sample clusters: one including K 
samples, one including P4, P7, and P6, and one including 
P1, P2, P3, and P5 (Figures 1C and D). K and PTB1 were 
separated from PTB2 by the first component (64.5%), 
while K was separated from PTB1 by the second com-
ponent (14.3%). Therefore, PCA carried out on histo-
pathological classification mirrored proteomic data and 
confirmed the PTB1/PTB2 clustering, characterized by 
a lower divergence of three samples (designated as PTB1 
cluster) and a higher divergence of the other four (des-
ignated as PTB2 cluster) from controls (K). Based on 
histopathological observations, PTB1 samples presented 
features more compatible with the definition of type 2 
lesions, while PTB2 samples were more compatible with 
the definition of type 3a lesions (Additional file 1).
Differential proteomic analysis
In view of the results obtained by PCA and hierarchical 
clustering of both proteomics and histopathology results, 
the differential proteomic analysis was carried out by 
comparing: (i) all PTB samples vs K; (ii) only PTB1 sam-
ples vs K; and (iii) only PTB2 samples vs K. Results are 
reported in Table 1 and in Additional file 3.
A total of 96 proteins showed statistically signifi-
cant differences (Table  1). Of these, 69 were higher 
and 27 were lower in PTB vs K, respectively. Of the 69 
increased proteins, 33 were statistically significant in all 
PTB samples, 6 only in PTB1, and 30 only in PTB2. Of 
the 27 decreased proteins, 9 were statistically significant 
in all PTB samples, 5 only in PTB1, and 13 only in PTB2 
(Table  1). The higher number of differential proteins 
detected in PTB2 samples indicates that these differ more 
than PTB1 samples from K, and suggests the presence 
of two different levels of tissue involvement in the PTB 
sample set. Eleven proteins were identified in the MAP 
database and included in the differential analysis (Addi-
tional file 3). Among them, only chaperone protein HtpG 
passed the thresholds for FC value and statistical signifi-
cance (Table 1).
KEGG enrichment and gene ontology analysis 
of differential proteins
Differential proteins were evaluated for protein networks 
by STRING. KEGG enrichment and GO results are sum-
marized in Additional file 4.
For the 69 proteins increased in all PTB samples, 
KEGG enrichment (Figure  2A) highlighted three 
main networks. The first network was phagosome 
(P = 5.97E−06), including V-type proton ATPase cata-
lytic subunit A (ATP6V1A), V-type proton ATPase 
subunit B (ATP6V1B2), V-type proton ATPase subu-
nit H (ATP6V1H), cathepsin S (CTSS), integrin beta-2 
(ITGB2), neutrophil cytosol factor 2 (NCF2), ras-
related protein Rab-5A (RAB5A), and protein transport 
protein Sec61 subunit gamma (SEC61G) (Figure  2B). 
The second network was tuberculosis (P = 1.03E−03), 
including ATP6V1H, cathelicidin 1 (CATHL1A), CTSS, 
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ITGB2, myeloid differentiation primary response 
protein MyD88 (MYD88), and RAB5A (Figure  2C). 
And the third network was lysosome (P = 2.82E−02), 
including acid ceramidase (ASAH1), ATP6V1H, CTSS, 
and IGF2R (Figure 2D). Figures 2B, C and D report the 
relative abundance (NSAF) of the proteins that describe 
the pathways. Eight out of these 11 proteins (ATP6V1A, 
ATP6V1B2, ATP6V1H, CTSS, IGF2R, ITGB2, NCF2, 
and RAB5A) were significantly higher only in PTB2. 
Only 4 proteins (ASAH1, CATHL1, MYD88, and 
SEC61G) were higher in both PTB1 and PTB2 clus-
ters and in all PTB samples analyzed together. Among 
these, MYD88 and SEC61G were similar in the two 
PTB clusters, while CATHL1 and ASAH1 were more 
abundant in PTB2.
GO analysis (Figure 3A) highlighted 5 main networks. 
The first network was defense response (P = 8.65E−05) 
with CATHL1A, cathelicidin 2 (CATHL2), scavenger 
receptor cysteine-rich type 1 protein M130 (CD163), 
chitinase-3-like protein 1 (CHI3L1), histone H2B type 
1 (H2B), haptoglobin (HP), MYD88, protein S100-A8 
(S100A8), and serum amyloid A protein (SAA2) 
(Figure  3B). The second network was inflammatory 
response (P = 5.61E−04) with CD163, CHI3L1, HP, 
MYD88, S100A8, and SAA2 (Figure 3C). The third net-
work was acute phase response (P = 3.47E−03) with 
CD163, HP, MYD88, and SAA2 (Figure 3D). The fourth 
network was cell chemotaxis (P = 2.25E−03) with 
ITGB2, ras-related protein Rab-13 (RAB13), S100A8, 
and SAA2 (Figure  3E). Finally, the fifth network was 
apoptotic process (P = 2.12E−02) with caspase-13 
(CASP4 or CASP13), CHI3L1, deoxyribonucle-
ase-1 (DNASE1), ERO1-like protein alpha (ERO1L or 
ERO1A), notchless protein homolog 1 (NLE1), and 
S100A8 (Figure 3F). These are described by a total of 15 
proteins, 11 of which are significant only in the PTB2 
cluster. As evidenced by KEGG enrichment analysis 
and GO analysis, proteins higher in PTB2 were likely 
associated with a more marked tissue alteration when 
compared to PTB1 and were characterized by numer-
ous processes associated with the presence of MAP.
The 27 proteins decreased in PTB (Figure  4A) were 
mainly involved in the networks biological process 
(P = 3.48E−02) and metabolic process (P = 3.48E−02) 
Figure 1 Clustering of samples according to protein abundance values and histopathological features. The two panels show the PCA 
clustering on top and the hierarchical clustering heatmap on the bottom. Left, clustering based on shotgun proteomics. Right; clustering based 
on histopathology. Two technical replicates were analyzed in shotgun proteomics experiments, and results are reported separately for the two 
replicates as a and b, respectively. P indicates paucibacillary samples; K indicates control samples. A Results of PCA based on protein abundance 
values in terms of normalized spectrum abundance factors (NSAFs). B Hierarchical clustering of samples based on NSAFs. Protein identities and 
abundances are reported in Additional file 3. C Results of PCA based on histopathological grading. D Hierarchical clustering of samples based on 
histopathological grading. Parameters and scores are detailed in Additional file 1.
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Table 1 Differential proteins in all PTB, PTB1 and PTB2 vs K samples, respectively 
Accession Gene name Description All PTB vs K PTB1 vs K PTB2 vs K
P62808 H2B Histone H2B type 1 138.55 159.95 122.71
P63048 UBA52 Ubiquitin-60S ribosomal protein L40 70.26 67.05 72.67
A0JNJ5 MYL1 Myosin light chain 1/3, skeletal muscle isoform 16.55 23.39 11.42
Q17QN3 SNRPN Small nuclear ribonucleoprotein-associated protein N 11.68 9.08 13.31
A1L595 KRT17 Keratin, type I cytoskeletal 17 11.29 13.98b 9.06
A0A0E2WA25 HtpG Chaperone protein HtpG 8.67 5.32 11.19
A2I7N0 SERPINA3-4 Serpin A3-4 6.70 7.62 6.05
Q9BE41 MYH2 Myosin-2 5.76 5.37 5.78
P22226 CATHL1A Cathelicidin-1 5.44 3.06 7.54
Q29437 AOCX Primary amine oxidase, liver isozyme 5.29 5.69 4.99b
Q56JX9 FABP2 Fatty acid-binding protein, intestinal 5.07 9.92 1.43b
Q3T104 SEC61G Protein transport protein Sec61 subunit gamma 4.69 4.21 5.28
Q17QB3 ASAH1 Acid ceramidase 3.75 3.11 4.17
P19660 CATHL2 Cathelicidin-2 3.67 2.14 5.10
Q5E972 ORMDL2 ORM1-like protein 2 3.28 2.69 3.73
Q9N0K1 CD47 Leukocyte surface antigen CD47 2.99 1.98b 3.40
Q0IIG7 RAB5A Ras-related protein Rab-5A 2.89 1.81b 3.70
P61625 ITGAL Integrin alpha-L 2.73 −1.17b 4.14
Q1JPB0 SERPINB1 Leukocyte elastase inhibitor 2.64 1.28b 3.72
P85521 CD163 Scavenger receptor cysteine-rich type 1 protein M130 2.56 1.14b 3.63
Q58DS5 RAB13 Ras-related protein Rab-13 2.50 2.33 2.40
Q9BDK2 AIF1 Allograft inflammatory factor 1 2.49 1.13b 3.51
P79106 PAFAH2 Platelet-activating factor acetylhydrolase 2 2.45 2.05b 2.76
P09578 MT1C Metallothionein-1C 2.44 2.35 2.43b
P83095 LACTB Serine beta-lactamase-like protein LACTB 2.44 1.39b 3.23
Q95JC7 SLC1A5 Neutral amino acid transporter B (0) 2.43 2.05b 2.72
P55156 MTTP Microsomal triglyceride transfer protein large subunit 2.37 3.45 1.56a
Q2YDN6 RPF2 Ribosome production factor 2 homolog 2.37 1.45b 3.06
P00766 CTRA Chymotrypsinogen A 2.21 −2.76 3.60
Q28035 GSTA1 Glutathione S-transferase A1 2.11 3.73 −1.11a
Q599T9 MYD88 Myeloid differentiation primary response protein MyD88 2.06 2.35 2.00
P61955 SUMO2 Small ubiquitin-related modifier 2 2.04 1.94b 2.12
Q95115 STAT5A Signal transducer and activator of transcription 5A 2.04 1.66b 2.33
Q3SWY9 RAB28 Ras-related protein Rab-28 1.73b 2.42 –
Q32L48 HIST1H2BN Histone H2B type 1-N 1.55b 2.25 1.01b
A7YWK3 KRT73 Keratin, type II cytoskeletal 73 1.49b 2.24 −1.08b
A2VDL6 ATP1A2 Sodium/potassium-transporting ATPase subunit alpha-2 1.44b 2.22 −1.16a
Q2TBP0 PSMB7 Proteasome subunit beta type-7 1.64a 2.10 1.30a
P14568 ASS1 Argininosuccinate synthase 1.40a 2.05 −1.09b
Q2TBU0 HP Haptoglobin 8.14b – 13.84
P00639 DNASE1 Deoxyribonuclease-1 3.97b −1.57b 6.48
P30922 CHI3L1 Chitinase-3-like protein 1 3.67b 1.16b 5.80
Q0P5C2 MTHFD2 Bifunctional methylenetetrahydrofolate dehydrogenase 3.04b 1.57b 3.92
Q1LZA3 ASNS Asparagine synthetase 2.44b 1.25b 3.53
P00760 TRY1 Cationic trypsin 1.92a 2.33b 3.03
O77775 NCF2 Neutrophil cytosol factor 2 2.25b 1.20b 3.03
P08169 IGF2R Cation-independent mannose-6-phosphate receptor 1.11b −1.05b 2.99
P28782 S100A8 Protein S100-A8 1.94b – 2.89
P32592 ITGB2 Integrin beta-2 1.86b 1.20b 2.64
Q2HJH7 MEMO1 Protein MEMO1 2.31b 1.85b 2.62
O75601 CASP13 Caspase-13 1.75a 1.01a 2.60
Page 7 of 15Pisanu et al. Vet Res          (2018) 49:117 
Table 1 (continued)
Accession Gene name Description All PTB vs K PTB1 vs K PTB2 vs K
O77588 PLOD1 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 1.91b −1.12b 2.57
Q5EAD2 PHGDH d-3-Phosphoglycerate dehydrogenase 1.98a 1.27b 2.51
A2VDZ9 VAPB Vesicle-associated membrane protein-associated protein B 2.15b 1.72b 2.46
P31408 ATP6V1B2 V-type proton ATPase subunit B 1.12b 1.06b 2.45
P25326 CTSS Cathepsin S 2.01b 1.15b 2.38
A5PJP1 BLOC1S3 Biogenesis of lysosome-related organelles complex 1 sub 3 1.76b – 2.38
Q29RY9 NPL N-acetylneuraminate lyase 1.74a 1.10a 2.36
A5PJN2 ERO1L ERO1-like protein alpha 1.72b 1.06b 2.30
Q2TBK3 PLAC9 Placenta-specific protein 9 1.71a 1.02b 2.23
P31404 ATP6V1A V-type proton ATPase catalytic subunit A 1.75a 1.11b 2.22
Q3ZBI6 FHL3 Four and a half LIM domains protein 3 1.70a 1.03b 2.21
Q3SZZ0 BRIX1 Ribosome biogenesis protein BRX1 homolog 1.88b 1.47b 2.18
O46563 ATP6V1H V-type proton ATPase subunit H 1.62b 1.11b 2.16
P35541 SAA1 Serum amyloid A protein 1.41b – 2.15
Q17QL5 TMEM30A Cell cycle control protein 50A 1.82b 1.49a 2.07
Q865V6 CAPG Macrophage-capping protein 1.56b −1.10b 2.05
Q58D20 NLE1 Notchless protein homolog 1 1.90b 1.74b 2.03
P06868 PLG Plasminogen 1.63b 1.17b 2.00
P80931 MCT1A Mast cell protease 1A −1.70b 1.19b −7.28
Q6B410 LYSI Lysozyme C −1.92b −1.07b −4.81
Q3SZX4 CA3 Carbonic anhydrase 3 −1.74b 1.03b −4.29
Q7YRZ7 GZMA Granzyme A −1.76a −1.16b −2.91
P19111 ALPI Intestinal-type alkaline phosphatase −1.28b 1.29b −2.62
A8YXX7 TFF3 Trefoil factor 3 −1.43b 1.11b −2.54
Q3T166 MPTX Mucosal pentraxin −1.01a 1.77b −2.52
Q28106 CNTN1 Contactin-1 −1.40b 1.12b −2.43
Q3MHR3 DYNLL2 Dynein light chain 2 −1.63b −1.22b −2.16
Q5EA62 FBLN5 Fibulin-5 −1.49b −1.05b −2.16
Q3MHN0 PSMB6 Proteasome subunit beta type-6 −1.63b −1.30b −2.16
Q3T0Z2 FABP6 Gastrotropin −1.85b −1.65b −2.05
P31836 NCAM1 Neural cell adhesion molecule 1 −1.49b −1.10b −2.02
Q2M2T1 HIST1H2BK Histone H2B type 1-K −1.24a −3.55 1.20a
Q3T052 ITIH4 Inter-alpha-trypsin inhibitor heavy chain H4 −0.83a −2.63 1.82b
P61823 RNASE1 Ribonuclease, pancreatic −1.11a −2.60 1.66a
Q29RQ9 ORMDL1 ORM1-like protein 1 −1.59b −2.25 −1.43b
A1A4Q4 TMA7 Translation machinery-associated protein 7 −1.00a −2.23 1.41b
Q32PH8 EEF1A2 Elongation factor 1-alpha 2 −2.01 −1.56a −2.57
Q0III9 ACTN3 Alpha-actinin-3 −2.36 −2.54 −2.24
P00978 IATR Inter-alpha-trypsin inhibitor −4.09 −4.38 −3.37
Q9BE39 MYH7 Myosin-7 −6.04 −6.80 −5.23
Q9BE40 MYH1 Myosin-1 −6.28 −7.08 −5.44
O62664 PTGS1 Prostaglandin G/H synthase 1 −6.39 −7.20 −5.54
Q58DW4 SNRPB Small nuclear ribonucleoprotein-associated protein B’ −6.81 −7.66 −5.90
Q32KN8 TUBA3 Tubulin alpha-3 chain −52.20 −60.66 −46.68
Q2HJ86 TUBA1D Tubulin alpha-1D chain −97.29 −113.10 −87.02
Differences in abundance are reported as fold changes in the respective sample comparisons. Statistically significant proteins are in bolditalics. The only statistically 
significant MAP protein is in italics.
In bolditalics: fold change ≤ −2 or ≥ 2, beta-binomial test P ≤ 0.05.
a Fold change ≥ −2 or ≤ 2, beta-binomial test P ≤ 0.05
b Any fold change with non-significant beta-binomial test.
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(Additional file  4). STRING revealed changes associ-
ated to cytoskeleton network (P = 1.17E−02), includ-
ing dynein light chain 2 (DYNLL2), myosin-1 (MYH1), 
myosin-7 (MYH7), tubulin alpha-1D chain (TUBA1D), 
and tubulin alpha-3 chain (TUBA3E) (Figure 4B). These 
proteins are also found in the networks: myosin com-
plex (P = 6.93E−04) including DYNLL2, MYH1 and 
MYH7, and microtubule (P = 3.05E−02) with DYNLL2, 
TUBA1, and TUBA3E.
IHC evaluation of selected differential proteins
Cathelicidin, haptoglobin, S100A8 and S100A9 were fur-
ther investigated by IHC to validate proteomic results 
and to explore their value as potential indicators of 
Figure 2 KEGG enrichment analysis of proteins significantly increased in PTB vs K. The figure reports the protein network and the proteins 
included in each category, with the respective abundance increases in all PTB samples, in PTB1, and in PTB2, respectively. A Protein network 
according to STRING. Proteins associated with phagosome, lysosome, and tuberculosis are indicated in red, green, and yellow, respectively. Seven 
different colored lines link nodes and represent seven types of evidence used in predicting associations. Green lines: neighborhood evidence; red 
lines: presence of fusion evidence; blue lines: co-occurrence evidence; black lines: co-expression evidence; purple lines: experimental evidence; 
light blue lines: database evidence; yellow lines: text-mining evidence. Plots show the relative abundances of proteins in the phagosome (B), 
lysosome (C), and tuberculosis (D) pathways. Plots report values obtained in K (sky blue), PTB (red), PTB1 (pink), and PTB2 (purple) samples. Asterisks 
indicate statistically significant differences between PTB vs K (*), PTB1 vs K (**), and PTB2 vs K (***) according to the t-test (p value ≤ 0.05). For protein 
identities corresponding to gene names, please see Table 1.
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disease severity or progression (Figure 5), in view of the 
observed differences in protein levels among samples 
and of their role in MAP infection and host immunity. 
Specifically, cathelicidin was selected because two dif-
ferent proteoforms (cathelicidin-1 and cathelicidin-2) 
were among the top 15 significantly higher proteins 
in PTB samples (Table  1), and also in consideration of 
its well-known role in mycobacterial killing [39] and 
innate immunity [40, 41]. Haptoglobin and S100A8 
were selected for being the first and the second protein 
significantly increased only in PTB2 (Table  1). S100A9 
was also assessed for being a subunit of the intestinal 
inflammation marker calprotectin together with S100A8 
[42]. Mean, standard deviation, median, interquartile 
ranges, and minimum–maximum values of the number 
of positive cells observed in a 200× magnification field 
are reported in Additional file  5 for each marker. As a 
result, K samples (Figure 5, first row) were always nega-
tive to cathelicidins and haptoglobin while S100A8 and 
S100A9 showed few scattered signals. Cells positive to 
all four proteins were readily detectable in PTB samples, 
with significantly lower numbers in PTB1 (Figure 5, sec-
ond row) than PTB2 (Figure 5, third row). Cathelicidin-
positive cells (Figure 5, first column) were about 30-fold 
higher in PTB2 (median value 1.00 in PTB1 vs 30.50 in 
PTB2, P < 0.0001) and were morphologically compatible 
with dendritic cells (DCs, stronger signals) or epithelial 
cells (weaker signals). Haptoglobin-positive cells (Fig-
ure 5, second column) were about 40-fold higher in PTB2 
than PTB1 (median value 0.00 in PTB1 vs 41.50 in PTB2, 
P < 0.0001). Haptoglobin was localized exclusively in cor-
respondence of macrophages. S100A8-positive cells (Fig-
ure 5, third column) were about threefold higher in PTB2 
(median value 6.00 in PTB1 vs 17.00 in PTB2, P < 0.0001). 
The cell type positive to S100A8 was compatible with 
Paneth cells for localization and morphology. S100A9-
positive cells (Figure 5, fourth column) were about sixfold 
higher in PTB2 (median value 6.00 in PTB1 vs 36.00 in 
PTB2, P < 0.001). In the case of S100A9, the positive cell 
type was not clearly recognizable in PTB1, while it was 
almost exclusively macrophages in PTB2.
Discussion
Differential shotgun proteomics enables to investigate 
the changes occurring in the protein makeup of a tissue 
in a condition of interest, such as in a pathological state 
against the physiological state. The proteomic approach 
presents advantages and disadvantages in comparison to 
gene expression strategies. One advantage is the ability 
to truly evaluate the extent of protein abundance, going 
beyond the estimates based on gene expression. In fact, 
several proteins do not follow a strict relationship with 
gene transcription but are regulated at translational or 
post-translational level, as in the case of cathelicidins [38, 
43]. Moreover, adding to changes in protein abundance, 
changes in protein localization can often be revealed 
including protein capture or release phenomena, pro-
vided that histological evaluations are carried out for fur-
ther investigation or validation. On the other hand, the 
number of samples in a high-performance shotgun prot-
eomics study is typically limited by analytical throughput 
and cost issues. In addition, the sensitivity of proteom-
ics is not as high as transcriptomics, and some relevant 
low-abundance, transient mediators may not be detected, 
including cytokines.
In this study, the application of shotgun proteomics to 
paucibacillary MAP-infected sheep ileal tissues (PTB) 
and matched MAP-free controls (K) highlighted sev-
eral host proteins and pathways that are altered by MAP 
upon infection. In addition, proteomic results and histo-
pathological grading revealed the presence of two PTB 
sample clusters, one with a higher (PTB2) and one with a 
lower proteomic divergence (PTB1) from K. That is, sev-
eral proteins associated with MAP infection and with its 
pathological process changed more intensely in the PTB2 
than in the PTB1 sample cluster. This was also reflected 
by the different abundance of the MAP chaperone pro-
tein HtpG in the two clusters, with FC values of 5.32 in 
PTB1 and 11.19 in PTB2, respectively. Based on histolog-
ical observations, the PTB1 and PTB2 proteomic profiles 
might relate to paucibacillary type 2 and type 3a lesions 
[22], indicating that the different levels of tissue altera-
tion and lesion severity found in sheep with subclinical, 
active, paucibacillary MAP infection might be associated 
to specific changes in their proteomic profiles.
According to KEGG enrichment analysis, the differen-
tial proteins seen in intestinal tissues of PTB sheep were 
mainly involved in phagosome formation, lysosome func-
tion and tuberculosis. This is due to the MAP strategy of 
survival within macrophages: impairment of phagosome 
and lysosome fusion. The mechanism is shared with 
other mycobacteria including the more intensively inves-
tigated M. tuberculosis [10]. Interestingly, most of these 
proteins changed significantly only in PTB2. Three out 
of eight proteins of the phagosome pathway were subu-
nits of the V-type proton ATPase complex (V-ATPase). 
V-ATPase is responsible for phagolysosome acidifica-
tion. By specifically excluding V-ATPase from this com-
partment, mycobacteria can survive and multiply within 
macrophages [10, 44]. Different authors have reported a 
higher expression of V-ATPase in MAP-infected mac-
rophages as compared to macrophages infected with 
non-pathogenic mycobacteria [45–47]. This finding is in 
line with our previous work on multibacillary PTB, where 
we observed an increase in most V-ATPase subunits. 
In that work, consistently with a higher MAP load and 
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Figure 3 GO analysis (biological process) of proteins significantly increased in PTB vs K. The figure reports the protein network and the proteins 
included in each category with the respective abundance increases in all PTB samples, in PTB1, and in PTB2, respectively. A Protein network according 
to STRING. Proteins associated with defense response, inflammatory response, acute phase response, cell chemotaxis, and apoptotic process, are 
reported in red, green, yellow, sky blue, and fuchsia, respectively. Seven different colored lines link nodes and represent seven types of evidence used 
in predicting associations. Green lines: neighborhood evidence; red lines: presence of fusion evidence; blue lines: co-occurrence evidence; black lines: 
co-expression evidence; purple lines: experimental evidence; light blue lines: database evidence; yellow lines: text-mining evidence. Plots show the 
relative abundances of proteins in defense response (B), in inflammatory response (C), acute phase response (D), cell chemotaxis (E), and apoptotic 
process (F), indicating values obtained in K (sky blue), PTB (red), PTB1 (pink), and PTB2 (purple) samples. Asterisks indicate statistically significant 
differences between PTB vs K (*), PTB1 vs K (**), and PTB2 vs K (***) according to the t-test (p value ≤ 0.05). For protein identities corresponding to gene 
names, please see Table 1.
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lesion severity, fold changes were very high for all subu-
nits and peaked up to a FC of 18.09 for subunit H, the 
specific target for mycobacterium-mediated exclusion 
[25, 44].
Changes in Rab GTPases were also observed. It is 
known that Rab5 stimulates fusion of early endosomes 
while Rab7 promotes fusion of mature phagosomes 
with endosomes and lysosomes [48]. By retaining Rab5, 
MAP impairs maturation of endosomes into functional 
mycobactericidal compartments [49]. In line with this, 
we observed that Rab5 was significantly increased in the 
PTB2 sample cluster (but not in PTB1). On the other 
hand, Rab7 was unchanged in both clusters, highlight-
ing the role of Rab5 in the mycobacterial pathogenicity 
mechanism. The increase seen in Rab13 does also relate 
to the relevance of the phagocytotic pathway in the host 
defense from MAP. Tubulins are involved in phagosome 
maturation, and their massive decrease seen in infected 
tissues might be related to the impairment of this process 
in MAP-infected macrophages.
According to GO analysis, most proteins undergo-
ing significant changes in MAP-infected tissues were 
involved in defense response, inflammatory response 
and acute phase response. Two isoforms of cathelicidin 
were increased in all PTB samples, with higher FC val-
ues in PTB2 vs PTB1. This result was also in line with our 
previous study on multibacillary PTB, (FCs of 24.53 for 
cathelicidin 1 and of 15.79 for cathelicidin 2) [25]. Cathel-
icidins are well-known antimicrobial peptides with a 
crucial role in the intracellular killing of mycobacteria in 
macrophages [39, 50]. Besides their direct antimicrobial 
functions, cathelicidins play multiple roles as inflamma-
tion mediators [51], and their importance in the innate 
immune defense of ruminant is highlighted by the unusu-
ally large number of genes compared to a single copy in 
most other mammalians, such as humans and mice [52]. 
Consistently with the proteomic data, IHC confirmed 
the absence of cathelicidin in K tissues and its presence 
in PTB tissues, with a significantly higher abundance in 
PTB2 vs PTB1. However, it was not possible to specifi-
cally identify the cathelicidin isoform(s) by IHC due to 
the polyclonal anti-cathelicidin antibodies used. Appar-
ently, DCs were responsible for most of the cathelicidin 
signal; however, such DC localization might be due to 
protein capture rather than to protein expression by DCs 
themselves. Based on studies in humans, cathelicidin 
(LL-37) is internalized by DCs with subsequent localiza-
tion primarily in the cytoplasmic compartment and then 
in the nucleus. This eventually leads to a suppression of 
their response to toll-like receptor ligands and renders 
DCs less capable to activate T lymphocytes. In other 
words, cathelicidins inhibit DC function [51, 53, 54]. 
Nevertheless, in human tuberculosis this is inverted by 
presence of vitamin D, in a finely regulated equilibrium 
between inhibition and stimulation of cathelicidin pro-
duction, DC regulation and Th1 differentiation [55]. This 
is only part of the puzzle governing the combined action 
Figure 4 GO analysis (cellular component) of proteins 
significantly decreased in PTB vs K. The figure reports the protein 
network and proteins included in the category with the respective 
abundance decreases in PTB samples, in PTB1, and in PTB2, 
respectively. A Network obtained by STRING. Proteins associated 
with cytoskeleton, myosin complex, and microtubule are reported 
in green, yellow, and red, respectively. Seven different colored lines 
link nodes and represent seven types of evidence used in predicting 
associations. Green lines: neighborhood evidence; red lines: presence 
of fusion evidence; blue lines: co-occurrence evidence; black lines: 
co-expression evidence; purple lines: experimental evidence; light 
blue lines: database evidence; yellow lines: text-mining evidence. 
B Plot illustrating the abundance of proteins in the cytoskeleton 
network obtained in K (sky blue), PTB (red), PTB1 (pink), and PTB2 
(purple) samples. Asterisks indicate statistically significant differences 
between PTB vs K (*), PTB1 vs K (**), and PTB2 vs K (***) according 
to the t-test (p value ≤ 0.05). For protein identities corresponding to 
gene names, please see Table 1.
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of genetic background, farming variables and environ-
mental conditions (such as nutritional balance and expo-
sure to light) in resistance of ruminants to mycobacterial 
diseases, in which the role of cathelicidin regulation of 
DCs might deserve further investigation.
Several proteins involved in the acute phase response 
were significantly changed in PTB vs K. Interestingly, 
haptoglobin, S100A8 and serum amyloid protein A were 
seen only in PTB2 samples and were not detected in 
PTB1 or K. This might underscore a potential role for 
these proteins as markers of disease progression, pos-
sibly indicating the activation of an acute inflammatory 
process when MAP infection is less controlled by the 
host. Of note, haptoglobin showed the highest increase 
among all the proteins significant only in PTB2 vs K, with 
a FC of 13.84. In our previous study on multibacillary 
MAP infection, haptoglobin showed a FC of 22.93 [25]. 
Here, upon IHC validation, haptoglobin was abundantly 
present in tissues of the PTB2 cluster while it was not 
detected in tissues of the PTB1 cluster. Notably, hapto-
globin-positive cells appeared to be almost exclusively 
macrophages. This might be related to its scavenging 
functions; in fact, haptoglobin captures hemoglobin by 
forming a complex that is promptly internalized by mac-
rophages. Its endocytosis and targeting to the lysosome 
are mediated by the macrophage receptor CD163 (scav-
enger receptor cysteine-rich type 1 protein M130) [56]. 
Consistently with this observation, CD163 was signifi-
cantly increased only in the PTB2 Cluster. Once again, 
the observed increase in protein abundance within the 
affected tissue is probably due to selective capture, rather 
than increased expression, by the cell. An increase in 
the CD163 receptor has been observed also in ileal tis-
sues of cattle infected by MAP [57]. It would be interest-
ing to investigate how an increased availability of iron 
within the macrophage phagosomes is reflected on MAP 
pathogenicity.
S100A8 plays a prominent role in the regulation of 
inflammation and immune response. It can induce neu-
trophil chemotaxis and adhesion, and it is predominantly 
found as the calprotectin heterodimer in association with 
S100A9, with a wide plethora of intra- and extracellu-
lar functions [58]. Fecal calprotectin is currently used in 
human medicine to differentiate organic from functional 
bowel disorders [42]. Upon IHC validation, S100A8 was 
detected in all PTB samples, but few, scattered posi-
tive cells were also present in K tissues. The number of 
S100A8-positive cells was about three times higher in 
PTB2 than PTB1. In consideration of its known associa-
tion with S100A9, it was surprising that the latter protein 
Figure 5 Immunohistochemistry results for selected differential proteins. Representative immunohistochemistry (IHC) images. First row. IHC 
results for negative control samples (K−). Second row. IHC results for PTB1 samples. Third row. IHC results for PTB2 samples.
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was not detected by proteomics in any of the experimen-
tal samples. However, S100A9 was readily detected by 
IHC in all PTB samples. The number of S100A9-positive 
cells was higher than that of S100A8-positive cells, and 
the cell type was also different. A possible explanation is 
that S100 proteins can also exist as homodimers [58], and 
a differential expression or a selective capture of S100A9 
by a specific cell type might be occurring.
Another protein significantly increased in PTB was pro-
tein transport protein Sec61 (SEC61). As recently discov-
ered, SEC61 is present in antigen-containing endosomes 
of DCs after stimulation with microbial substances and is 
essential for endosome-to-cytosol translocation and for 
antigen cross-presentation to T cells [59]. This pathway 
enables DCs to present extracellular antigens onto MHC 
I molecules, thereby stimulating naive cytotoxic CD8+ T 
cells into activated cytotoxic CD8+ T cells. This is only 
part of the complex mechanisms responsible for the pre-
dominance of the Th1 or Th2 response, a crucial step in 
the control of mycobacterial infections.
H2B was the most increased protein in all PTB samples. 
This might relate to the well-known antimicrobial role of 
histones. On the other hand, ubiquitin was the second 
highest protein, and this might indicate the occurrence 
of an extensive histone ubiquitination [60]. Nevertheless, 
it should be reminded that shotgun proteomics results as 
analyzed and presented here can only provide informa-
tion on relative protein abundance. These data can give 
useful hints on protein networks and pathways activated 
upon infection, but indications on protein structure, pro-
tein interactions or post-translational modifications need 
dedicated experimental investigations or data analysis 
algorithms.
Adding to proteins increased in PTB2, proteins sig-
nificantly increased only in samples of the PTB1 cluster 
(such as fatty acid-binding protein, glutathione S-trans-
ferase, Na/K-transporting ATPase, argininosuccinate 
synthase) or detected only in the PTB1 cluster (such as 
Rab-28), could also be worth investigating further; these 
proteins might represent potential indicators of a better 
ability to contrast disease and, should this be demon-
strated, have potential as targets in genetic selection for 
resistance to mycobacterial diseases.
Finally, as anticipated, it should be reminded that this 
study was carried out on a limited number of animals 
due to methodological constraints. Stringent statistic 
procedures were applied in differential proteomic analy-
sis and IHC validation confirmed the main study find-
ings, but observations such as the relationship of PTB1 
and PTB2 clusters with type 2 and type 3a lesions or any 
hypothesis on their connection with disease progression 
or increased pathogenicity and associated pathways will 
need to be investigated further with studies on a larger, 
well-characterized sample cohort by means of higher 
throughput techniques, such as IHC or other molecu-
lar tests, for a thorough validation on the entire range 
of lesions including also multibacillary cases. It should 
also be highlighted that low-abundance mediators such 
as cytokines were not identified in this study, as in most 
shotgun proteomics studies. However, these have been 
investigated in detail by other authors in paucibacillary 
PTB [17, 20, 61, 62].
In conclusion, this work provided the first detailed pro-
teomic characterization of paucibacillary MAP-infected 
sheep ileal tissues in comparison to MAP-free tissues. 
The differential proteomic analysis combined with immu-
nohistochemical validation highlighted several changes 
occurring in PTB tissues and provided novel molecular 
information on the distinct levels of tissue involvement 
that can be found within the asymptomatic, paucibacil-
lary condition. Adding to useful insights into disease pro-
cesses and pathways, we identified several proteins that 
are absent in healthy tissues and are present in MAP-
infected tissues, with differences in abundance levels or 
localization possibly reflecting different degrees of lesion 
severity. These host protein markers can assist future 
investigations aimed at understanding PTB evolution and 
progression, either with classical post-mortem analysis 
of tissues or, hopefully, by enabling the development of 
immunoassay tools for their in vivo detection in feces.
Additional files
Additional file 1. Histopathological grading scores and histopatho-
logical features of the PTB1 and PTB2 cluster samples. The file 
describes in detail: i) the grading scores assigned to all sheep tissue sam-
ples considered in this study; ii) Hematoxylin–Eosin and Ziehl–Neelsen 
stained panoramic and detailed views of PTB1 and PTB2 tissues illustrating 
their main features.
Additional file 2. Number of identified proteins, peptides, PSMs and 
Search Inputs in K and P samples. The file contains a table with the 
detailed report of all the results obtained for each tissue sample, and the 
average values measured in K and P samples.
Additional file 3. Protein identification details and differential pro-
teomic results based on label-free quantitation. Excel file reporting: 
the list of all proteins identified in each sample with the detailed data for 
coverage, proteins, unique peptides, and PSMs; the average NSAF value of 
each sheep protein in all experimental samples; the average NSAF value 
of each MAP protein in all experimental samples; and the complete list of 
all differential proteins detected in PTB vs K, PTB1 vs K, and PTB2 vs K, with 
the respective  RSC, FC, beta-binomial p value, and beta-binomial p value 
after Benjamini–Hochberg correction.
Additional file 4. Results of KEGG enrichment analysis and GO analy-
sis. Excel file reporting the detailed results obtained with STRING for KEGG 
enrichment analysis, Biological process, Molecular function and Cellular 
component.
Additional file 5. Column statistics of IHC results. Table reporting the 
mean, standard deviation (SD), median, interquartile range (IQR), mini-
mum and maximum (Min–Max) value of the number of cells measured in 
a 200× magnification field of the distal ileum in PTB1 and PTB2 sheep.
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